Phenotypic resistance to lenacapavir and monotherapy efficacy in a proof-of-concept clinical study. Margot N, Vanderveen L, Naik V, Ram R, et al. J Antimicrob Chemother 2022;77:989-995.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Margot N, Vanderveen L, Naik V, Ram R, et al. Phenotypic resistance to lenacapavir and monotherapy efficacy in a proof-of-concept clinical study. J Antimicrob Chemother 2022;77:989-995.
PMID: 35028668